Article Information
- Received January 31, 2011
- Revision received March 10, 2011
- Accepted March 20, 2011
- First published May 4, 2011.
- Version of record published May 4, 2011.
Author Information
- Boris B. Quednow1,2,9,
- Ulrich Ettinger3,4,
- Rainald Mössner2,
- Dan Rujescu5,
- Ina Giegling5,
- David A. Collier6,
- Anne Schmechtig7,
- Kai-Uwe Kühn2,
- Hans-Jürgen Möller3,
- Wolfgang Maier2,
- Michael Wagner2,*, and
- Veena Kumari7,8,*
- 1University Hospital of Psychiatry, Division of Experimental and Clinical Pharmacopsychology, University of Zurich, CH-8032 Zurich, Switzerland,
- 2Department of Psychiatry and Psychotherapy, University of Bonn, D-53105 Bonn, Germany,
- 3Departments of Psychiatry and
- 4Psychology and
- 5Division of Molecular and Clinical Neurobiology, Ludwig-Maximilians University Munich, D-80337 Munich, Germany,
- 6Social, Genetic and Developmental Psychiatry Centre,
- 7Department of Psychology, Institute of Psychiatry, King's College London, and
- 8National Institute for Health Research Biomedical Research Centre for Mental Health, South London and Maudsley National Health Service Foundation Trust, SE5 8AF London, United Kingdom, and
- 9Zurich Center for Integrative Human Physiology, University of Zurich, CH-8057 Zurich, Switzerland
Author contributions
-
Author contributions: B.B.Q., U.E., R.M., D.A.C., K.-U.K., H.-J.M., W.M., M.W., and V.K. designed research; B.B.Q., U.E., R.M., D.R., I.G., D.A.C., A.S., K.-U.K., M.W., and V.K. performed research; D.R., I.G., and D.A.C. contributed unpublished reagents/analytic tools; B.B.Q., R.M., D.R., M.W., and V.K. analyzed data; B.B.Q., U.E., R.M., D.A.C., M.W., and V.K. wrote the paper.
-
↵*M.W. and V.K. contributed equally to this work.
Disclosures
- Received January 31, 2011.
- Revision received March 10, 2011.
- Accepted March 20, 2011.
-
Dr. Quednow was supported by the Swiss National Science Foundation (Grant PP00P1_123516). He also had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Dr. Ettinger was supported by the German Research Foundation (DFG) (Grant ET 31/2-1). Dr. Wagner was supported by the DFG (Grant WA 737/7). Drs. Maier and Mössner were supported by the European Union (Grant FP7-Health-F4-2009-242257-ADAMS) and by the German Federal Ministry for Education and Research (BMBF) (Grants POSITIVE 01GV0907, NGFN+ MooDs PNM-01GS08146-3). Dr. Collier, Dr. Ettinger, and Anne Schmechtig were supported by the European Commission (Grant FP6-2005-LIFESCIHEALTH-7, STREP project 037,761, SGENE). Dr. Kumari was supported by the Wellcome Trust (067427/z/02). The study was funded in part by the Federal Ministry of Education and Research within the scope of the German Research Network on Schizophrenia (Grants 01-GI-0232, 01-GI-0236, and 01-GI-9934). We are grateful to Tobias Bast (Centre for Cognitive and Neural Systems, University of Edinburgh), Anita Rauch (Institute of Medical Genetics, University of Zurich), and Lea Hulka (University Hospital of Psychiatry, University of Zurich) for helpful comments and suggestions to the manuscript. We thank Vera Guttenthaler for excellent technical assistance.
- Correspondence should be addressed to Dr. Boris B. Quednow, Division of Experimental and Clinical Pharmacopsychology, University Hospital of Psychiatry, Lenggstrasse 31, CH-8032 Zurich, Switzerland. quednow{at}bli.uzh.ch
Statistics from Altmetric.com
Article usage
In this issue
